What happens when you marry a background in genetic engineering with extensive experience in design? A unique skill set that supports life scientists in becoming entrepreneurs, helping PhDs turn benchtop science into applied products with the potential to change lives. Arvind Gupta is the co-founder of IndieBio, the world’s largest seed biotech accelerator. He has over a decade of experience helping startups and Fortune 50 companies launch new tech products, and his thought-leadership has been published in Time, Design Observer, and Rotman Management Magazine, among others. Arvind has received a number of international awards for design and innovation, and he is a frequent speaker at events like SFMOMA and TEDx New Silk Road. Today Arvind shares his take on how the future of humanity rests in biology, explaining how advances in technology have facilitated better, faster results in scientific research. We discuss how the IndieBio approach takes capital expenditure out of the system and coverts it into operating expenses for biotech startups. We cover the current trends in biotechnology, where to go for information about the industry, and the types of companies Arvind is looking for right now. Listen and learn what the term CRISPR really means and how this powerful technology will eventually allow us to “design ourselves.”
What happens when you marry a background in genetic engineering with extensive experience in design? A unique skill set that supports life scientists in becoming entrepreneurs, helping PhDs turn benchtop science into applied products with the potential to change lives.
Arvind Gupta is the co-founder of IndieBio, the world’s largest seed biotech accelerator. He has over a decade of experience helping startups and Fortune 50 companies launch new tech products, and his thought-leadership has been published in Time, Design Observer, and Rotman Management Magazine, among others. Arvind has received a number of international awards for design and innovation, and he is a frequent speaker at events like SFMOMA and TEDx New Silk Road.
Today Arvind shares his take on how the future of humanity rests in biology, explaining how advances in technology have facilitated better, faster results in scientific research. We discuss how the IndieBio approach takes capital expenditure out of the system and coverts it into operating expenses for biotech startups. We cover the current trends in biotechnology, where to go for information about the industry, and the types of companies Arvind is looking for right now. Listen and learn what the term CRISPR really means and how this powerful technology will eventually allow us to “design ourselves.”
Connect with Arvind
IndieBio http://indiebio.co/
Twitter https://twitter.com/arvndgpta
Resources Mentioned
SynBioBeta https://synbiobeta.com/
LifeSciVC https://lifescivc.com/
MIT Technology Review https://www.technologyreview.com/
Scientific American https://www.scientificamerican.com/
New Scientist https://www.newscientist.com/
The History of Money by Jack Weatherford https://www.amazon.com/History-Money-Jack-Weatherford/dp/0609801724
Connect with Boost VC
Boost VC Website https://www.boost.vc/
Boost VC on Facebook https://www.facebook.com/boostvc/
Boost VC on Twitter https://twitter.com/BoostVC